- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2014
- Public Summary Document (PSD) November 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2014 PBAC Meeting - Word
Cetuximab – November 2014
Cetuximab; solution for intravenous (IV) infusion, 100 mg in 20 mL & 500 mg in 100 mL; Erbitux®
Last updated
6 March 2015